
GHB and the closely related substance GBL should become classified as Class B drugs under the Misuse of Drugs Act
Read MoreGHB and the closely related substance GBL should become classified as Class B drugs under the Misuse of Drugs Act
Read MoreThree experts in topics including clinical toxicology, drug markets, social research and social care have been appointed to the Advisory
Read MoreThe Advisory Council on the Misuse of Drugs (ACMD) has recommended that three novel benzodiazepine-type substances be controlled. In a
Read MoreIn response to the COVID-19 pandemic, the UK Home Secretary is seeking to relax the regulations on prescribing controlled drugs.
Read MoreThe Advisory Council for the Misuse of Drugs (ACMD) have published a comprehensive report on the synthetic opioid fentanyl and
Read MoreProfessor Alex Stevens, a senior member of the Advisory Council on the Misuse of Drugs (ACMD), has resigned over the
Read MoreSix new experts in topics including pharmacology, pharmacy, and health economics have been recruited to help deliver the Advisory Council
Read MorePrescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from next April, the UK
Read MoreThe UK government has announced that cannabis-based products for medicinal use will be available for specialist doctors to prescribe legally
Read MoreThe Home Secretary has appointed new members to the Advisory Council on the Misuse of Drugs (ACMD). Experts in topics
Read More